|
|
Substance Name: Flurazepam hydrochloride [USAN:USP:JAN]
RN: 1172-18-5
UNII: 756RDM536M
InChIKey: ZIIJJOPLRSCQNX-UHFFFAOYSA-N
Note
- A benzodiazepine derivative used mainly as a hypnotic.
Molecular Formula
- C21-H23-Cl-F-N3-O.2Cl-H
Molecular Weight
- 460.8055
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
Classification Codes
- Anticonvulsant
- Drug / Therapeutic Agent
- Relaxant (Muscle)
- Sedative-Hypnotic
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Flurazepam dihydrochloride
- Flurazepam hydrochloride [USAN:USP:JAN]
Synonyms
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
- 7-Chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride
- Benozil
- Dalmadorm
- Dalmane
- Dalmate
- EINECS 214-630-0
- Felison
- Flurazepam dihydrochloride
- Flurazepam HCl
- Flurazepam hydrochloride
- ID 480
- Insumin
- Insumin dihydrochloride
- Linzac
- Lunipax
- Natam
- NSC-78559
- Ro 5-6901
- Somlan
- UNII-756RDM536M
Systematic Names
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-, 1,3-dihydro-, dihydrochloride
- Flurazepam hydrochloride
Superlist Names
- Dalmane
- DEA No. 2767
- Flurazepam
- Flurazepam hydrochloride
Registry Numbers
CAS Registry Number
- 1172-18-5
FDA UNII
- 756RDM536M
Related Registry Number
- 17617-23-1 (Parent)
System Generated Number
- 0001172185
Molecular Formulas
Molecular Formula
- C21-H23-Cl-F-N3-O.2Cl-H
Molecular Formula Fragments
- C21-H23-Cl-F-N3-O
- Cl-H
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C21H23ClFN3O.2ClH/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23;;/h5-10,13H,3-4,11-12,14H2,1-2H3;2*1HInChIKey
ZIIJJOPLRSCQNX-UHFFFAOYSA-NSmiles
Cl.Cl.CCN(CC)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 186mg/kg (186mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
mouse | LD50 | intravenous | 59100ug/kg (59.1mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
mouse | LD50 | oral | 596mg/kg (596mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
mouse | LD50 | subcutaneous | 440mg/kg (440mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 637, 1977. |
rabbit | LD50 | oral | 568mg/kg (568mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 178, Pg. 216, 1969. |
rat | LD50 | intraperitoneal | 152mg/kg (152mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
rat | LD50 | intravenous | 38700ug/kg (38.7mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
rat | LD50 | oral | 879mg/kg (879mg/kg) | Yakkyoku. Pharmacy. Vol. 26, Pg. 741, 1975. | |
rat | LD50 | subcutaneous | 859mg/kg (859mg/kg) | Drugs in Japan Vol. 6, Pg. 706, 1982. |